Possible increased risks of cholecystitis in patients with idiopathic pulmonary fibrosis treated with nintedanib. [PDF]
Kiani C +4 more
europepmc +1 more source
Cough in idiopathic pulmonary fibrosis: what is new. [PDF]
Carvalho da Silva MA +3 more
europepmc +1 more source
Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis. [PDF]
Golchin N +7 more
europepmc +1 more source
Mechanisms on How Matricellular Microenvironments Sustain Idiopathic Pulmonary Fibrosis. [PDF]
Jones N +5 more
europepmc +1 more source
Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis. [PDF]
Selman M, Buendia-Roldan I, Pardo A.
europepmc +1 more source
Ferroptosis: the potential key roles in idiopathic pulmonary fibrosis. [PDF]
Song L, Gao F, Man J.
europepmc +1 more source
The Hypoxia-Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential. [PDF]
Paz-Gomez D +16 more
europepmc +1 more source
Polygenic Risk and Rare Variants in Endotypes of Idiopathic Pulmonary Fibrosis
Duckworth A +18 more
europepmc +1 more source
Use of supplemental oxygen therapy in idiopathic pulmonary fibrosis: an observational real-life study in 16 003 patients. [PDF]
Marant-Micallef C +8 more
europepmc +1 more source

